Denver, Colorado
Colorectal cancer clinical trials in Denver, CO
27 colorectal cancer studies are recruiting participants at sites in Denver as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Denver at a glance
- 27 studies are recruiting at a site in Denver.
- By phase: Phase 1 (7), Phase 1/2 (8), Phase 2 (1), Phase 2/3 (1), Phase 3 (4), No phase (2), Observational (4). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (20), university, hospital or other (6), government (1).
- Most recent update to one of these records: November 10, 2026.
Studies recruiting in Denver
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT07503808 · updated
The Vanguard Study: Testing a New Way to Screen for Cancer
- No phase
- Ages 45 to 75
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Kaiser Permanente-Franklin
- Registry record
- NCT06995898 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Registry record
- NCT07228832 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Kaiser Permanente-Franklin
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Study sites
- Denver Health Medical Center · Kaiser Permanente-Franklin · Saint Joseph Hospital - Cancer Centers of Colorado
- Registry record
- NCT05174169 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Study site
- AdventHealth Porter
- Registry record
- NCT05334069 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Study sites
- Colorado Blood Cancer Institute · Kaiser Permanente-Franklin · Rocky Mountain Cancer Centers-Midtown
- Registry record
- NCT06418204 · updated
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Rocky Mountain Cancer Centers
- Registry record
- NCT06662786 · updated
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Sarah Cannon Cancer Institute at HealthONE
- Registry record
- NCT06720987 · updated
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Rocky Mountain Cancer Centers
- Registry record
- NCT06750094 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT04657068 · updated
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- ModeX Therapeutics, An OPKO Health Company
- Study site
- Sarah Cannon Research Institute
- Registry record
- NCT06239194 · updated
SMP-3124LP in Adults With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Sumitomo Pharma America, Inc.
- Study site
- Sarah Cannon Research Institute at HealthOne
- Registry record
- NCT06526819 · updated
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BioNTech SE
- Study site
- SCRI at HCA Health One
- Registry record
- NCT07186842 · updated
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kura Oncology, Inc.
- Study site
- Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT06026410 · updated
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study sites
- Intermountain Health Cancer Center Saint Joseph · Intermountain Health Saint Joseph Hospital · Intermountain Health Saint Joseph Hospital - Research Office
- Registry record
- NCT07222800 · updated
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- PMV Pharmaceuticals, Inc
- Study site
- Rocky Mountain Cancer Center
- Registry record
- NCT04585750 · updated
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Phanes Therapeutics
- Study site
- Sarah Cannon Research Institute (SCRI)
- Registry record
- NCT05482893 · updated
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sutro Biopharma, Inc.
- Study site
- SCRI Denver
- Registry record
- NCT07227168 · updated
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ArriVent BioPharma, Inc.
- Study site
- Sarah Cannon Research Institute
- Registry record
- NCT07066657 · updated
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Sarah Cannon Research Institue At Healthone
- Registry record
- NCT06179160 · updated
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- RasCal Therapeutics, Inc.
- Study site
- Sarah Cannon, SCRI Oncology Partners - Health One
- Registry record
- NCT04678648 · updated
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- SCRI Development Innovations, LLC
- Study site
- Rocky Mountain Cancer Center - Primary
- Registry record
- NCT07011576 · updated
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- SCRI - Denver
- Registry record
- NCT03947385 · updated
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- Observational
- Ages 18 to 49
- All sexes
- Sponsor
- San Raffaele University
- Study site
- Department of Medicine-Gastroenterology, Denver Veterans Affairs Medical Center, University of Colorado Hospital
- Registry record
- NCT05732623 · updated
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tasca Therapeutics
- Study site
- Sarah Cannon Research Institute at HealthONE
- Registry record
- NCT07030257 · updated
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Observational
- All ages
- All sexes
- Sponsor
- Massive Bio, Inc.
- Study site
- Massive Bio SYNERGY-AI site
- Registry record
- NCT03452774 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Denver, CO on ClinicalTrials.gov.
Ask about studies near Denver
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Colorado
All Colorado locations
73 studies recruiting across 29 cities.
Aurora
43 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections